Short report: Pre-existing cross-reactive antibodies to avian influenza H5N1 and 2009 pandemic H1N1 in US military personnel

American Journal of Tropical Medicine and Hygiene

Volumn 90, Issue 1, 2014, Pages 149-152

  Pichyangkul, Sathit ^a   Krasaesub, Somporn ^a   Jongkaewwattana, Anan ^b   Thitithanyanont, Arunee ^c   Wiboon ut, Suwimon ^c   Yongvanitchit, Kosol ^a   Limsalakpetch, Amporn ^a   Kum Arb, Utaiwan ^a   Mongkolsirichaikul, Duangrat ^a   Khemnu, Nuanpan ^a   Mahanonda, Rangsini ^d   Garcia, Jean Michel ^e   Mason, Carl J ^a   Walsh, Douglas S ^a   Saunders, David L ^a  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^c Mahidol University ^*  (Thailand)

^d CHULALONGKORN UNIVERSITY   (Thailand)

^e HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; INFLUENZA VACCINE; VIRUS ANTIBODY; VIRUS PROTEIN; NEUTRALIZING ANTIBODY;

2009 H1N1 INFLUENZA; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; MAJOR CLINICAL STUDY; MALE; NEURAMINIDASE INHIBITION ASSAY; SERODIAGNOSIS; SOLDIER; VIRUS NEUTRALIZATION; YOUNG ADULT; AGED; BLOOD; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MIDDLE AGED; RISK; UNITED STATES; VIROLOGY;

ADULT; AGED; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MILITARY PERSONNEL; NEUTRALIZATION TESTS; ODDS RATIO; UNITED STATES;

EID: 84892779258     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0151     Document Type: Article

References (14)

1. RubertoneMV, Brundage JF, 2002. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health 92: 1900-1904.
2. Lee MS, Yang CF, 2003. Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains. J Infect Dis 188: 1362-1366.
3. Mendelman PM, Rappaport R, Cho I, Block S, Gruber W, August M, Dawson D, Cordova J, Kemble G, Mahmood K, Palladino G, Lee MS, Razmpour A, Stoddard J, Forrest BD, 2004. Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain. Pediatr Infect Dis J 23: 1053-1055.
4. Lambre CR, Terzidis H, Greffard A, Webster RG, 1990. Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. J Immunol Methods 135: 49-57.
5. Garcia JM, Lagarde N, Ma ES, de Jong MD, Peiris JS, 2010. Optimization and evaluation of an influenza A (H5) pseudotyped lentiviral particle-based serological assay. J Clin Virol 47: 29-33.
6. Koyama S, Aoshi T, Tanimoto T, Kumagai Y, Kobiyama K, Tougan T, Sakurai K, Coban C, Horii T, Akira S, Ishii KJ, 2010. Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci Transl Med 2: 25-24.
7. Johns MC, Eick AA, Blazes DL, Lee SE, Perdue CL, Lipnick R, Vest KG, Russell KL, DeFraites RF, Sanchez JL, 2010. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS One 5: e10722.
8. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM, 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
9. Tang JW, Tambyah PA, Wilder-Smith A, Puong KY, Shaw R, Barr IG, Chan KP, 2010. Crosss-reactive antibodies to pandemic (H1N1) 2009 virus, Singapore. Emerg Infect Dis 16: 874-876.
10. Chen H, Wang Y, Liu W, Zhang J, Dong B, Fan X, de Jong MD, Farrar J, Riley S, Smith GJ, Guan Y, 2009. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis 15: 1849-1850.
11. Grabenstein JD, Pittman PR, Greenwood JT, Engler RJ, 2006. Immunization to protect the USArmed Forces: heritage, current practice, and prospects. Epidemiol Rev 28: 3-26.
12. Murphy BR, Kasel JA, Chanock RM, 1972. Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med 286: 1329-1332.
13. Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ, 2007. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 4: e59.
14. Smallman-Raynor M, Cliff AD, 2007. Avian influenza A (H5N1) age distribution in humans. Emerg Infect Dis 13: 510-512.